Stockreport

Acorda Therapeutics Announces Commercial Launch of INBRIJA™ (levodopa inhalation powder)

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF First and Only FDA-Approved Inhaled Levodopa for On-demand Use for OFF Periods in People with Parkinson’s Taking Carbidopa/Levodopa ARDSLEY, N.Y.-- [Read more]